Download
tdi prevalence n.
Skip this Video
Loading SlideShow in 5 Seconds..
TDI &Prevalence PowerPoint Presentation
Download Presentation
TDI &Prevalence

TDI &Prevalence

100 Vues Download Presentation
Télécharger la présentation

TDI &Prevalence

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. TDI &Prevalence First results of pilotproject A.W.Ouwehand W.Kuijpers Lisbon: TDI meeting september 2006

  2. TDI & Prevalence • Flash back at the project • The project • The First Data • First Analysis • Questions /First Answers • Comments experts Lisbon: TDI meeting september 2006

  3. TDI Measures • New treatments. • Repeated treatments after an administrative break.

  4. Definitions • All Treatments: All clients started in reference period.(EMCDDA) • Total Treatments: All clients in treatment in reference period (Pilot)

  5. TDI does Not • Register continuous treatment relations. • Give a total view of treatment demand. • Give a clear view on trends in addiction and treatment demand. • Compare to national reports.

  6. Proposal in Scientific Board ….. memo to extendthe TDI to total prevalence “In its current form, however, the TDI does not give insight into the total treatment demand. Especially chronic clients that have been registered for longer periods are not reported by TDI-figures. Addiction being a chronic disease, chronicclients consequently form a substantial part of the total treatment demand. To give an impression about a country's total treatment demand and the number of drug addicts that are being reached by treatment, it is therefore proposed to extend the TDI to all drug treatment cases for a given reporting year. Comparing incidence cases to existing cases will also give further insight into the division between new and old drug problems in Member States of the European Union.”

  7. Questions to start • Would it be possible to deliver the total treatment demand besides the 2005 TDI data? • Could it eventually be done at a later date (year)? • How can we advice the EMCDDA (Management Board/Scientific Board)? • Will it be possible for all/some countries? • In what way does this effect the figures of the EMCDDA and the presentation of TDI data?

  8. K1 K2 K3 K4 K5 K6 K7 K8 K9 K10 K11 Indicator of prevalence 2 All Clients in Treatment in 2005 2005 2006

  9. Pilot • Participating countries (data delivered) • Au,Bg,Cz,F,Lv,Nl • Participants Pl,MT,GR,HU (but no data delivered yet) • Data collection IVZ Netherlands (W.Kuijpers) • Based on 2004 and/or 2005 data • Data structure: First ,All, Total treatment • Presentation on “EMCDDA”level

  10. The First Data Not for publication

  11. The First Data Not for publication

  12. Primary problem condensed Not for publication

  13. Primary problem condensed Not for publication

  14. Primary problem condensedin percentages Not for publication

  15. Age distribution Not for publication

  16. Age distribution Not for publication

  17. Questions/First Answers • Would it be possible to deliver the total treatment demand besides the 2005 TDI data? • Several countries are able to deliver these data • Could it eventually be done at a later date (year)? • Yes • How can we advice the EMCDDA (Management Board/Scientific Board)? • To continue and widen up the experimenton voluntary base • Will it be possible for all/some countries? • Has to be further discussed/investigated • In what way does this effect the figures of the EMCDDA and the presentation of TDI data? • Most likely significantly